000			02002 a2200529 4500
005			20250518090244.0
264		0	_c20200622
008			202006s 0 0 eng d
022			_a1524-4733
024	7		_a10.1016/j.jval.2019.08.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aDoshi, Jalpa A
245	0	0	_aTrends and Factors Associated With Insurer Approval of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Prescriptions. _h[electronic resource]
260			_bValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research _c02 2020
300			_a209-216 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAnticholesteremic Agents _xadverse effects
650	0	4	_aCross-Sectional Studies
650	0	4	_aDatabases, Factual
650	0	4	_aDrug Costs
650	0	4	_aDrug Prescriptions
650	0	4	_aEligibility Determination _xeconomics
650	0	4	_aFemale
650	0	4	_aFormularies as Topic
650	0	4	_aHealth Care Rationing _xeconomics
650	0	4	_aHealth Services Accessibility _xeconomics
650	0	4	_aHumans
650	0	4	_aInsurance Coverage _xeconomics
650	0	4	_aInsurance, Pharmaceutical Services _xeconomics
650	0	4	_aMale
650	0	4	_aMedicare _xeconomics
650	0	4	_aMiddle Aged
650	0	4	_aPCSK9 Inhibitors
650	0	4	_aPrior Authorization _xeconomics
650	0	4	_aSerine Proteinase Inhibitors _xadverse effects
650	0	4	_aTime Factors
650	0	4	_aUnited States
700	1		_aLi, Pengxiang
700	1		_aPuckett, Justin T
700	1		_aPettit, Amy R
700	1		_aRaman, Swathi
700	1		_aParmacek, Michael S
700	1		_aRader, Daniel J
773	0		_tValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research _gvol. 23 _gno. 2 _gp. 209-216
856	4	0	_uhttps://doi.org/10.1016/j.jval.2019.08.011 _zAvailable from publisher's website
999			_c30688022 _d30688022